Acella, the makers of NP Thyroid, issued a voluntary recall notice on May 22, 2020. This is part 2 of a two-part series reviewing the drug recall notice’s statements and the science behind them. [Part 1: Acella NP Thyroid recall:… Read More ›
Thyroid pharma
Acella NP Thyroid recall: Ethical yet low-risk
Acella, the makers of NP Thyroid, issued a voluntary recall notice on May 22, 2020. This is part 1 of a two-part series reviewing the drug recall notice’s statements and the science behind them. In this post, I put this… Read More ›
Thyroid patient blaming and shaming, part 3: Advocacy and Science
In this Part 3, I continue my rebuttal of a research article that blames thyroid patients for causing harm to themselves by making requests of doctors for tests and therapies.
In this post, I explain the good signs that thyroid patients’ self-advocacy is sometimes effective and is making a difference.
2019 ATA article engages in patient-blaming and doctor-shaming
Some members of the American Thyroid Association (ATA) have achieved a new ethical low. They have published in their official scientific journal, Thyroid, an article that blames thyroid patients for causing harm to themselves by making requests of doctors for… Read More ›
L-T3 pharmaceutical equivalency, Part 2: New thyroid science
What does NEW thyroid science have to say on the topic of thyroid pharmaceutical equivalency? How many micrograms of L-T3 Liothyronine (i.e. Cytomel) are equivalent to L-T4 Levothyroxine (i.e. Synthroid)? Thyroid hormone pharmaceutical monographs currently provide very rigid and low-ratio… Read More ›
No, 25 mcg of L-T3 Liothyronine isn’t equivalent to 100 mcg L-T4
In thyroid therapy, how many micrograms of Cytomel (T3) are equivalent to how many micrograms of Synthroid (T4)? Equivalency statements in the product monographs for Pfizer Canada’s Cytomel and for ERFA Canada’s “Thyroid” (NDT brand) claim that a 25 mcg… Read More ›
Global thyroid pharma economics: T3 meds
Here’s an update on prices in some locations of the world, and Canada, for synthetic T3 medication, known by the chemical name liothyroinine. UNITED KINGDOM & GREECE A Daily Mail article published May 27, 2019 reported the prices for T3… Read More ›
2014 ATA Therapy guidelines: 3. Desiccated thyroid
If we want to disagree with the American Thyroid Association’s prejudice against animal sources of thyroid hormone, we should to at least prove we’re trying to listen to them. Then we should fairly point out what they didn’t say, what truths… Read More ›